The aetiological role of viruses in carcinoma of the lower female genital tract has been the focus of much research. The association between human papilloma virus (HPV) and cervical neoplasia is well known, although definitive proof of the causal role for this virus is still inconclusive.' Moreover, HPV has also been detected in vulval squamous cell carcinoma. 2 The role of synergistic carcinogenic factors such as two or more viruses interacting at different stages of carcinogenesis has been considered. 3 Epstein Barr Virus (EBV) is an oncogenic herpes virus associated with certain B cell lymphomas in humans and also with epithelial tumours such as nasopharyngeal carcinoma. 4 EBV has also been found to replicate in cervical epithelium, and its possible role in the development of cervical carcinoma has been raised. The oligonucleotide primers used for amplification of EBV spanned a region of 122 base pairs within the first internal repeat (IRI) of EBV DNA from base 1399 to 1520. The oligonucleotide reporter probe spans the intervening region within the first internal repeat (IR1) from base 1424 to 1439 (table) .
Amplification for EBV DNA was carried out using the GeneAmp DNA amplification reagent kit with cloned Taq DNA polymerase (Perkin Elmer Cetus) using conditions reported before. 6 The amplified products were analysed by gel electrophoresis in 4% NuSieve 3 in 1 agarose gel (FMC), followed by ethidium bromide staining.
The specificity of the amplified EBV DNA product was confirmed by Southern blotting of the gel, followed by probing of the membrane with 32P-labelled oligomeric reporter probe. The oligonucleotide reporter probe used was for the amplified BamHl W region of the EBV genome (1424-1439).
DNA extracted from Burkitt's lymphoid cell line infected with EBV, Raji (ATCC, Maryland, USA), was used as a positive control and DNA from rat spleen tissue sections was used as a negative control.
On all samples negative for EBV DNA, analysis using human ,B globin gene as an internal control was performed by PCR amplification followed by Southern blot. amplified viruses, such as cytomegalovirus (CMV) and DNA was human papillomavirus (HPV).4 This mechaLt cases of nism can provide a selfsustaining reservoir of I DNA was infection in the lower female genital tract. A introl cases similar study of cervical carcinoma done in nplification our laboratory also showed a 44-5% inci-I in all the dence of EBV DNA detected in normal cervical tissue compared with a similar 48-8% incidence in cases of cervical carcinoma."1 Our study also showed, unusually, that EBV DNA is rare in vulval carcinoma, suggesting that EBV is probably not involved in the development of vulval carcinoma. Such findings are consistent with the observations obtained from a local study on cervical carcinomall mentioned above. In that study the prevalence of EBV DNA in the control group of non-neoplastic cervical tissue and the group of patients with invasive carcinoma of the cervix was the same. The finding of a lack of association between EBV and cancer of the lower female genital tract in Hong Kong is E BV significant and contrasts with the known 22bp strong association between EBV and neoplasia in the upper respiratory tract in Hong Kong-namely, nasopharyngeal carcinoma.612 In situ hybridisation studies were performed using an EBER 1 and 2 probe for anti-sense RNA, but they failed to show any signal from any of the cases. The EBV DNA detected by PCR in the four control cases may have been below the detection level of in situ hybridisation
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techniques.
110bp
We conclude that EBV is not associated with vulval carcinoma. Moreover, the detection of EBV in non-neoplastic vulval epithe- 
